At a price of Rs 1,252.03 per share, promoter Docon Technologies sold 53.3 lakh shares (10.06 percent of paid-up stock) in Thyrocare Technologies for Rs 667.7 crore.
Through open market transactions on October 24, promoter Docon Technologies decreased its ownership of Thyrocare Technologies, the supplier of diagnostic services, by little over 10%, with asset management firms purchasing 7.9% of the company’s shares.
Thyrocare shares maintained above all significant moving averages as they finished 1.13 percent higher at Rs 1,266.1 on the National Stock Exchange with strong volumes.
Docon Technologies, which as of September 2025 owned 71.06 percent of the firm, sold 53.3 lakh shares (10.06 percent of paid-up equity) for Rs 667.7 crore at a price of Rs 1,252.03 per share.
Aditya Birla Sun Life Mutual Fund, HDFC Mutual Fund, ICICI Prudential Mutual Fund, HSBC Mutual Fund Midcap Fund, and Eastspring Investments India Consumer Equity Open paid Rs 1,252 per share for 42.1 lakh shares (7.9 percent ownership) for a total of Rs 527.2 crore.
Through the ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D.) Fund, ICICI Prudential Mutual Fund previously owned 2.2 percent of Thyrocare. On Friday, it may increase its total ownership to 5.5 percent by purchasing an additional 3.3 percent of shares.
Midwest, a manufacturer of black galaxy granite, had significant activity as well, with shares rising 7% to Rs 1,140.5 on the company’s first day of trading today. The business is worth Rs 4,126 crore.
For Rs 50.05 crore, Goldman Sachs Funds-Goldman Sachs India Equity Portfolio purchased 4.34 lakh shares (1.2 percent of the Midwest) at a price of Rs 1,152.56 a share.